Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

BCL7A Antikörper (Middle Region)

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch BCL7A in WB. Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN632344

Kurzübersicht für BCL7A Antikörper (Middle Region) (ABIN632344)

Target

Alle BCL7A Antikörper anzeigen
BCL7A (B-Cell CLL/lymphoma 7A (BCL7A))

Reaktivität

  • 29
  • 8
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Human

Wirt

  • 28
  • 1
Kaninchen

Klonalität

  • 29
Polyklonal

Konjugat

  • 17
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser BCL7A Antikörper ist unkonjugiert

Applikation

  • 22
  • 13
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB)
  • Bindungsspezifität

    • 10
    • 3
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Middle Region

    Spezifität

    BCL7 A antibody was raised against the middle region of BCL7

    Aufreinigung

    Affinity purified

    Immunogen

    BCL7 A antibody was raised using the middle region of BCL7 corresponding to a region with amino acids CGSEVTTPENSSSPGMMDMHDDNSNQSSIADASPIKQENSSNSSPAPEPN
  • Applikationshinweise

    WB: 1 µg/mL
    Optimal conditions should be determined by the investigator.

    Kommentare

    BCL7A Blocking Peptide, (ABIN937090), is also available for use as a blocking control in assays to test for specificity of this BCL7A antibody

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Lyophilized powder. Add distilled water for a 1 mg/mL concentration of BCL0 antibody in PBS

    Konzentration

    Lot specific

    Buffer

    PBS

    Handhabung

    Avoid repeated freeze/thaw cycles.
    Dilute only prior to immediate use.

    Lagerung

    4 °C/-20 °C

    Informationen zur Lagerung

    Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
  • Target

    BCL7A (B-Cell CLL/lymphoma 7A (BCL7A))

    Andere Bezeichnung

    BCL7A

    Hintergrund

    This gene is directly involved, with Myc and IgH, in a three-way gene translocation in a Burkitt lymphoma cell line. As a result of the gene translocation, the N-terminal region of the gene product is disrupted, which is thought to be related to the pathogenesis of a subset of high-grade B cell non-Hodgkin lymphoma. The N-terminal segment involved in the translocation includes the region that shares a strong sequence similarity with those of BCL7B and BCL7C. Two transcript variants encoding different isoforms have been found for this gene.

    Molekulargewicht

    25 kDa (MW of target protein)
Sie sind hier:
Chat with us!